Loading company…
Shanghai Celliver develops cell therapy products and services, including those for liver disease.
Founded in 2013 and based in Shanghai, Shanghai Celliver develops cell therapy solutions for liver disease, with product lines for auxiliary reagents, cell preparations and stem cell CDMO/CMO services. In 2019, it completed a 2,000-square-meter GMP plant. It raised CNY 14 million from Shanghai Kinetic Medical Co., Ltd. in October 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in